Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
about
Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulinAn orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cellsCellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virusCrystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsCombinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusionAnti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptaseNP-06: a novel anti-human immunodeficiency virus polypeptide produced by a Streptomyces speciesEffects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoproteinSurvivors Remorse: antibody-mediated protection against HIV-1.Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteinsProtein intrinsic disorder toolbox for comparative analysis of viral proteins.Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production.Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeysDeterminants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo.Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous.Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primatesA continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoproteinTargeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.HIV-1 protein Nef inhibits activity of ATP-binding cassette transporter A1 by targeting endoplasmic reticulum chaperone calnexinThe membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusionConcordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodiesStructural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.
P2860
Q24523422-AA47C7FE-822B-4878-A97F-DC932A83CC75Q24527250-2D691A26-7065-478B-B917-BCE53F0451D7Q24806134-7C2C085F-6927-4234-8687-DB9F247D703AQ27486056-B844A204-70B6-4B16-87D8-4669F84675E7Q27667679-F5213602-C656-4628-9364-0E8F21D550BDQ28339853-2CCA43E1-04FE-49ED-A53C-89D057EA35D9Q28368943-1A5EFD3C-3E6D-4CF1-BD28-BA20A17633DDQ28378745-1933C1D7-F375-4FBC-8646-2D9A59365AACQ28378834-834ECB17-1D33-4091-84B1-4F7980802403Q28646850-B9C398ED-934F-45A8-BC88-AF0CFA9AED14Q30238730-F16370BA-8D8D-48C6-8AD4-513520689455Q30407161-109F8013-C0A2-41E0-A23E-6C25D878ECCDQ33373579-22B6D954-90DA-43F5-89A9-BC365C562109Q33551775-B30049F1-7A16-4901-A4AA-73E765186C47Q33649657-6B13C3E8-2801-4113-9790-1D34385F0CA6Q33782866-1AE0F0C9-15DF-488D-8386-6FA6FB3C8D75Q33783763-E016BAA2-6B41-4568-8730-C3CBD5981D36Q33785114-01DDD0A7-D770-4C47-83BC-C7EE07C390DFQ33821658-46572570-ADB4-45BC-95C6-C5F42FF19CCFQ33825327-1D681AB9-54A4-401A-A562-D1324394EFD0Q33850605-6C6DC7F6-D19B-40C5-8610-D08E164F141FQ33880904-A0F29B1E-E5AA-4A35-88AB-A0BD3C266A96Q33927239-964F8B01-50C1-45C9-B9FF-FBE191C1F221Q33931700-0168BC4B-D96B-4090-B9B6-1B678899BDF1Q33933855-020B2F65-3857-4510-B23D-939C42515D67Q33935010-CC8F2321-8646-4FD5-8C87-DF6343784C8EQ33936268-0A7E53D6-1716-44E2-BFD6-FB62D5F4A9AEQ33937274-22959E31-4BBD-4994-82DB-F1039E6866CEQ34200458-4B9E5FA1-651D-4641-B717-E6ABEC3E436AQ34280044-F99190B2-1392-494B-B4AC-B5013865153DQ34301897-44F897FD-53AD-4214-9DBB-E558B78B4C61Q34313555-D1CB8BE1-BA9C-400F-927E-A1148469604FQ34355599-9DE03B29-858C-4C18-A38A-F888B7C80FE5Q34358880-E770B134-44F6-4D5D-AAA7-91513DBBDB45Q34461554-22702FC7-E620-4110-A92D-38B9A7BBDB89Q34545996-DA8313A6-902F-4445-A545-93F41E2CB197Q34847834-304A73E3-ED45-45FC-AAD4-08539A2CCF14Q34998032-DA5CED5A-9184-4300-825E-C1B29920C79EQ35113720-863B935D-BFFE-421B-A2A8-18D860ECDE34Q35137168-B13AEF15-9B82-4185-B014-29E018B06C31
P2860
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Characterization of a human im ...... g of the neutralizing epitope.
@en
type
label
Characterization of a human im ...... g of the neutralizing epitope.
@en
prefLabel
Characterization of a human im ...... g of the neutralizing epitope.
@en
P2093
P2860
P1433
P1476
Characterization of a human im ...... g of the neutralizing epitope.
@en
P2093
K Javaherian
K Takatsuki
M Robert-Guroff
S Matsushita
P2860
P304
P407
P577
1988-06-01T00:00:00Z